PropertyValue
?:abstract
  • The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.
?:creator
?:doi
?:doi
  • 10.1253/circj.cj-20-0566
?:journal
  • Circulation_journal_:_official_journal_of_the_Japanese_Circulation_Society
?:license
  • cc-by-nc-nd
?:pmid
?:pmid
  • 32908073
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Management of Atrial Fibrillation in COVID-19 Pandemic.
?:type
?:year
  • 2020-09-09

Metadata

Anon_0  
expand all